Study shows guidelines vary for RhD testing and prophylaxis
A recent study revealed variations in international guidelines on RhD testing and prophylaxis, demonstrating the need for further research.
A recent study revealed variations in international guidelines on RhD testing and prophylaxis, demonstrating the need for further research.
Researchers updated the 2016 guidelines for evaluating blood antibodies in HDFN in order to improve diagnosis and fetal outcomes.
Researchers surveyed experts in fetal medicine and hematology to form a set of recommendations for managing HDFN.
Pregnant patients with multiple antibodies associated with HDFN may be at increased risk of complications including preterm birth.
A technical report summarized current data regarding the use of phototherapy in infants with hyperbilirubinemia, a common sign of HDFN.
A case study reports a severe case of hemolytic disease of the fetus and newborn (HDFN) caused by both anti-D and anti-C antibodies.